Evidence map›Paper›PMID 29213740›Full record

ReviewDementia & neuropsychologia

Cognitive, functional and behavioral assessment: Alzheimer's disease.

Márcia L F Chaves, Claudia C Godinho, Claudia S Porto, Leticia Mansur, Maria Teresa Carthery-Goulart, Mônica S Yassuda, Rogério Beato, Group Recommendations in Alzheimer’s Disease and Vascular Dementia of the Brazilian Academy of Neurology

Open access · diamondAbstract readReview
In one paragraph

Review in Dementia & neuropsychologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Dementia in Latin America: An Emergent Silent Tsunami.Frontiers in aging neuroscience · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Márcia L F ChavesNeurology Service of the Hospital de Clínicas of Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre RS, Brazil.
Claudia C GodinhoNeurology Service of the Hospital de Clínicas of Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre RS, Brazil.
Claudia S PortoCognitive and Behavioral Neurology Group of the Department of Neurology of the University of São Paulo School of Medicine, Hospital das Clínicas of the University of São Paulo School of Medicine, and Center for Mathematics, Computing and Cognition, Federal University of ABC, São Paulo SP, Brazil.
Leticia MansurCognitive and Behavioral Neurology Group of the Department of Neurology of the University of São Paulo School of Medicine, Hospital das Clínicas of the University of São Paulo School of Medicine, and Center for Mathematics, Computing and Cognition, Federal University of ABC, São Paulo SP, Brazil.
Maria Teresa Carthery-GoulartCognitive and Behavioral Neurology Group of the Department of Neurology of the University of São Paulo School of Medicine, Hospital das Clínicas of the University of São Paulo School of Medicine, and Center for Mathematics, Computing and Cognition, Federal University of ABC, São Paulo SP, Brazil.
Mônica S YassudaCognitive and Behavioral Neurology Group of the Department of Neurology of the University of São Paulo School of Medicine, Hospital das Clínicas of the University of São Paulo School of Medicine, and Center for Mathematics, Computing and Cognition, Federal University of ABC, São Paulo SP, Brazil.
Rogério BeatoResearch Group in Cognitive and Behavioral Neurology, Department of Internal Medicine, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte MG, Brazil.
Group Recommendations in Alzheimer’s Disease and Vascular Dementia of the Brazilian Academy of Neurology
Universidade de São Paulo · BRUniversidade Federal do Rio Grande do Sul · BRUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A review of the evidence on cognitive, functional and behavioral assessment for the diagnosis of dementia due to Alzheimer's disease (AD) is presented with revision and broadening of the recommendations on the use of tests and batteries in Brazil for the diagnosis of dementia due to AD. A systematic review of the literature (MEDLINE, LILACS and SCIELO database) was carried out by a panel of experts. Studies on the validation and/or adaptation of tests, scales and batteries for the Brazilian population were analyzed and classified according to level of evidence. There were sufficient data to recommend the IQCODE, DAFS-R, DAD, ADL-Q and Bayer scale for the evaluation of instrumental activities of daily living, and the Katz scale for the assessment of basic activities of daily living. For the evaluation of neuropsychiatric symptoms, the Neuropsychiatric Inventory (NPI) and the CAMDEX were found to be useful, as was the Cornell scale for depression in dementia. The Mini-Mental State Examination has clinical utility as a screening test, as do the multifunctional batteries (CAMCOG-R, ADAS-COG, CERAD and MDRS) for brief evaluations of several cognitive domains. There was sufficient evidence to recommend the CDR scale for clinical and severity assessment of dementia. Tests for Brazilian Portuguese are recommended by cognitive domain based on available data.

Indexed as

behavioral assessmentcognitive evaluationconsensusfunctional assessmentguidelines

Identifiers

PMID29213740
PMCPMC5619475
OpenAlexW1522527914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.